WOCKHARDT | UNICHEM LAB | WOCKHARDT/ UNICHEM LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -86.7 | -49.7 | - | View Chart |
P/BV | x | 1.9 | 1.2 | 157.4% | View Chart |
Dividend Yield | % | 0.0 | 1.1 | 0.2% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WOCKHARDT Mar-18 |
UNICHEM LAB Mar-19 |
WOCKHARDT/ UNICHEM LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,012 | 292 | 346.6% | |
Low | Rs | 532 | 182 | 292.0% | |
Sales per share (Unadj.) | Rs | 355.9 | 167.7 | 212.2% | |
Earnings per share (Unadj.) | Rs | -60.3 | -3.6 | 1,660.2% | |
Cash flow per share (Unadj.) | Rs | -46.8 | 5.9 | -787.0% | |
Dividends per share (Unadj.) | Rs | 0.01 | 4.00 | 0.3% | |
Dividend yield (eoy) | % | 0 | 1.7 | 0.1% | |
Book value per share (Unadj.) | Rs | 257.8 | 372.3 | 69.3% | |
Shares outstanding (eoy) | m | 110.63 | 70.38 | 157.2% | |
Bonus/Rights/Conversions | - | ESOP | - | ||
Price / Sales ratio | x | 2.2 | 1.4 | 153.4% | |
Avg P/E ratio | x | -12.8 | -65.3 | 19.6% | |
P/CF ratio (eoy) | x | -16.5 | 39.9 | -41.4% | |
Price / Book Value ratio | x | 3.0 | 0.6 | 470.2% | |
Dividend payout | % | 0 | -110.2 | 0.0% | |
Avg Mkt Cap | Rs m | 85,379 | 16,680 | 511.9% | |
No. of employees | `000 | 6.3 | 2.6 | 240.4% | |
Total wages/salary | Rs m | 9,371 | 2,393 | 391.6% | |
Avg. sales/employee | Rs Th | 6,295.0 | 4,535.2 | 138.8% | |
Avg. wages/employee | Rs Th | 1,498.3 | 919.8 | 162.9% | |
Avg. net profit/employee | Rs Th | -1,066.3 | -98.2 | 1,085.8% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 39,369 | 11,801 | 333.6% | |
Other income | Rs m | 1,202 | 984 | 122.2% | |
Total revenues | Rs m | 40,571 | 12,785 | 317.3% | |
Gross profit | Rs m | 18 | -835 | -2.2% | |
Depreciation | Rs m | 1,495 | 674 | 222.0% | |
Interest | Rs m | 2,555 | 75 | 3,397.5% | |
Profit before tax | Rs m | -2,830 | -600 | 471.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 1 | 0.0% | |
Extraordinary Inc (Exp) | Rs m | -3,582 | 0 | - | |
Tax | Rs m | 257 | -343 | -74.8% | |
Profit after tax | Rs m | -6,669 | -256 | 2,609.7% | |
Gross profit margin | % | 0 | -7.1 | -0.7% | |
Effective tax rate | % | -9.1 | 57.3 | -15.9% | |
Net profit margin | % | -16.9 | -2.2 | 782.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 33,796 | 20,384 | 165.8% | |
Current liabilities | Rs m | 26,917 | 5,029 | 535.2% | |
Net working cap to sales | % | 17.5 | 130.1 | 13.4% | |
Current ratio | x | 1.3 | 4.1 | 31.0% | |
Inventory Days | Days | 79 | 105 | 75.7% | |
Debtors Days | Days | 89 | 135 | 66.2% | |
Net fixed assets | Rs m | 39,664 | 9,023 | 439.6% | |
Share capital | Rs m | 553 | 141 | 392.9% | |
"Free" reserves | Rs m | 27,968 | 26,058 | 107.3% | |
Net worth | Rs m | 28,522 | 26,199 | 108.9% | |
Long term debt | Rs m | 21,731 | 0 | - | |
Total assets | Rs m | 81,620 | 31,496 | 259.1% | |
Interest coverage | x | -0.1 | -7.0 | 1.5% | |
Debt to equity ratio | x | 0.8 | 0 | - | |
Sales to assets ratio | x | 0.5 | 0.4 | 128.7% | |
Return on assets | % | -5.0 | -0.6 | 880.3% | |
Return on equity | % | -23.4 | -1.0 | 2,397.2% | |
Return on capital | % | -7.7 | -2.0 | 383.9% | |
Exports to sales | % | 0 | 69.4 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 8,188 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 9,807 | 8,188 | 119.8% | |
Fx outflow | Rs m | 1,789 | 596 | 300.1% | |
Net fx | Rs m | 8,019 | 7,592 | 105.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 684 | -3,278 | -20.9% | |
From Investments | Rs m | 6,302 | -2,860 | -220.4% | |
From Financial Activity | Rs m | -7,695 | -24 | 31,796.3% | |
Net Cashflow | Rs m | -664 | -4,690 | 14.2% |
Indian Promoters | % | 74.5 | 50.1 | 148.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.3 | 15.1 | 15.2% | |
FIIs | % | 7.7 | 3.0 | 256.7% | |
ADR/GDR | % | 0.1 | 0.0 | - | |
Free float | % | 15.4 | 31.7 | 48.6% | |
Shareholders | 67,757 | 20,176 | 335.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WOCKHARDT With: ALEMBIC PHARMA DISHMAN PHARMA J.B.CHEMICALS ASTRAZENECA PHARMA BIOCON
Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Asian stock markets are trading on a negative note today as rising US Treasury yields again rattled equity investors while hoisting the dollar to a three-month high.
For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.
For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.
For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.
Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.
For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this video, I'll show you how to allocate your capital as a day trader.
More